Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. (2015)

First Author: Glynne-Jones R
Attributed to:  Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-015-1764-1

PubMed Identifier: 26493588

Publication URI: http://europepmc.org/abstract/MED/26493588

Type: Journal Article/Review

Volume: 15

Parent Publication: BMC cancer

ISSN: 1471-2407